Skip to nav Skip to content
Martine  Extermann

Martine Extermann, MD, PhD

Program Lead, Senior Adult Oncology
Program Leader, Senior Adult Oncology Program
4.9 (222)

Specialty: Medical Oncology

Program: Senior Adult Oncology

Language(s): English

  • Overview

    Cancer Focus:
    Anal Cancer, Breast Cancer, Colon Cancer, Colorectal Cancer, Esophageal Cancer, Gallbladder Cancer, Hodgkin Lymphoma, Inflammatory Breast Cancer, Liver Cancer, Non-Hodgkin Lymphoma, Pancreatic Cancer, Stomach (Gastric) Cancer, Triple Negative Breast Cancer

    Dr. Extermann is Program Leader in the Senior Adult Oncology Program at Moffitt Cancer Center.  Dr. Martine Extermann is also a Professor of Oncology and Medicine at the University of South Florida. She earned her medical degree and a PhD at the University of Geneva, Switzerland.  She has a Swiss Board Certification in Internal Medicine, specializing in Hematology-Oncology.  She also holds ABIM certifications in Internal Medicine and Medical Oncology. She has worked at Moffitt since 1994 and has been a faculty member since 1997. Her clinical activity and research focus on cancer in older patients.  Her main areas of investigation are how cancer behavior and its treatment are influenced by the general health of the patient and other diseases they have, how to predict and optimize treatment tolerance, and how to include the benefits of a comprehensive geriatric assessment (CGA) for cancer patients. Dr Extermann’s research has received numerous grants from the National Institutes of Health and foundations such as e.g., the American Cancer Society and the Kay Yow Cancer Fund/V Foundation. She has served as President of the International Society of Geriatric Oncology (SIOG) and is also a founding board member. She is the chair of the SIOG CGA task force. She serves on several American Society of Clinical Oncology (ASCO) Committees and the Editorial Board of scientific journals. Dr. Extermann has been presented with the following awards: The B.J. Kennedy Award for Scientific Excellence in Geriatric Oncology from ASCO in 2009; The Paul Calabresi Award from SIOG in 2014; A Lifetime Achievement Award in Geriatric Oncology by the German Society of Geriatrics and German Society of Hematology/Oncology in 2015. 

    Education & Training


    • University Hospital (CHUV) Lausanne - Hematology
    • University of South Florida College of Medicine - Medical Oncology/Senior Adult Oncology


    • Hospital de la Chaux-de-Fonds - Surgery
    • Hospital Cantonal de Fribourg and University Hospital, Geneva - Internal Medicine

    Medical School:

    • University of Geneva, Switzerland - MD
  • Publications

    • Mandelblatt J, Dage JL, Zhou X, Small BJ, Ahles TA, Ahn J, Artese A, Bethea TN, Breen EC, Carroll JE, Cohen HJ, Extermann M, Graham D, Isaacs C, Jim HSL, Mcdonald BC, Nakamura ZM, Patel SK, Rebeck GW, Rentscher KE, Root JC, Russ KA, Tometich DB, Turner RS, Van Dyk K, Zhai W, Huang LW, Saykin AJ. Alzheimer's disease-related biomarkers and cancer-related cognitive decline: the thinking and living with cancer study. J Natl Cancer Inst. 2024 May. Pubmedid: 38788675.
    • Akhtar OS, Modi K, Kim J, Skellson L, Smith E, Al-Jumayli MA, Extermann M, De Avila G, Parker N, Castaneda-Puglianini O, Grajales-Cruz A, Baz R, Blue B, Shain K, Alsina M, Liu H, Nishihori T, Jain MD, Locke FL, Hansen DK, Freeman CL. Simple Score of Albumin and CRP Predicts High-Grade Toxicity in Patients with Multiple Myeloma Receiving CAR-T Therapy. Transplant Cell Ther. 2024 Mar.30(3):283.e1-283.e10. Pubmedid: 38123069.
    • Akhtar OS, Sheeba BA, Azad F, Alessi L, Hansen D, Alsina M, Baz R, Shain K, Grajales Cruz A, Castaneda Puglianini O, Liu H, Blue B, Nishihori T, Al Jumayli M, Extermann M, Locke FL, Mhaskar R, Freeman CL. Safety and efficacy of anti-BCMA CAR-T cell therapy in older adults with multiple myeloma: A systematic review and meta-analysis. Geriatr Oncol. 2024 Mar.15(2):101628. Pubmedid: 37723045.
    • Extermann M, Artz A, Rebollo MA, Klepin HD, Krug U, Loh KP, Mims AS, Neuendorff N, Santini V, Stauder R, Vey N. Treating acute myelogenous leukemia in patients aged 70 and above: Recommendations from the International Society of Geriatric Oncology (SIOG). Geriatr Oncol. 2024 Mar.15(2):101626. Pubmedid: 37741771.
    • Rozental A, Halperin E, Leibovitch C, Barzili M, Michowitz MK, Duek A, Rozovski U, Extermann M, Raanani P, Shacham-Abulafia A. CML in the very elderly: the impact of comorbidities and TKI selection in a real-life multicenter study. Ann Hematol. 2024 Jun. Pubmedid: 38862792.
    • Gillis N, Dickey BL, Colin-Leitzinger C, Tang YH, Putney RM, Mesa TE, Yoder SJ, Suneja G, Spivak AM, Patel AB, Extermann M, Giuliano AR, Teng M, Kresovich J, Berglund A, Coghill AE. Clonal hematopoiesis in patients with HIV and cancer. J Infect Dis. 2024 Apr. Pubmedid: 38657098.
    • Rentscher KE, Bethea TN, Zhai W, Small BJ, Zhou X, Ahles TA, Ahn J, Breen EC, Cohen HJ, Extermann M, Graham DMA, Jim HSL, McDonald BC, Nakamura ZM, Patel SK, Root JC, Saykin AJ, Van Dyk K, Mandelblatt JS, Carroll JE. Epigenetic aging in older breast cancer survivors and noncancer controls: preliminary findings from the Thinking and Living with Cancer Study. Cancer. 2023 Sep.129(17):2741-2753. Pubmedid: 37259669.
    • Rozental A, Jim HSL, Extermann M. Treatment of older patients with mantle cell lymphoma in the era of novel agents. Leuk Lymphoma. 2023 Sep.64(9):1514-1526. Pubmedid: 37357622.
    • Seghers PAL, Alibhai SMH, Battisti NML, Kanesvaran R, Extermann M, O'Donovan A, Pilleron S, Mislang AR, Musolino N, Cheung KL, Staines A, Girvalaki C, Soubeyran P, Portielje JEA, Rostoft S, Hamaker ME, Trépel D, O'Hanlon S. Geriatric assessment for older people with cancer: policy recommendations. Glob Health Res Policy. 2023 Sep.8(1):37. Pubmedid: 37653521. Pmcid: PMC10472678.
    • Nakamura ZM, Small BJ, Zhai W, Ahles TA, Ahn J, Artese AL, Bethea TN, Breen EC, Cohen HJ, Extermann M, Graham D, Irwin MR, Isaacs C, Jim HSL, Kuhlman KR, McDonald BC, Patel SK, Rentscher KE, Root JC, Saykin AJ, Tometich DB, Van Dyk K, Zhou X, Mandelblatt JS, Carroll JE. Depressive symptom trajectories in older breast cancer survivors: the Thinking and Living with Cancer Study. J Cancer Surviv. 2023 Nov. Pubmedid: 37924476.
    • Dickey BL, Putney RM, Suneja G, Kresovich JK, Spivak AM, Patel AB, Teng M, Extermann M, Giuliano AR, Gillis N, Berglund A, Coghill AE. Differences in epigenetic age by HIV status among patients with a non-AIDS defining cancer. Aids. 2023 Nov.37(13):2049-2057. Pubmedid: 37467055. Pmcid: PMC10538418.
    • Carroll JE, Nakamura ZM, Small BJ, Zhou X, Cohen HJ, Ahles TA, Ahn J, Bethea TN, Extermann M, Graham D, Isaacs C, Jim HSL, Jacobsen PB, McDonald BC, Patel SK, Rentscher K, Root J, Saykin AJ, Tometich DB, Van Dyk K, Zhai W, Breen EC, Mandelblatt JS. Elevated C-Reactive Protein and Subsequent Patient-Reported Cognitive Problems in Older Breast Cancer Survivors: The Thinking and Living With Cancer Study. J Clin Oncol. 2023 Jan.41(2):295-306. Pubmedid: 36179271. Pmcid: PMC9839283.
    • Mandelblatt JS, Small BJ, Zhou X, Nakamura ZM, Cohen HJ, Ahles TA, Ahn J, Bethea TN, Extermann M, Graham D, Isaacs C, Jacobsen PB, Jim HSL, McDonald BC, Patel SK, Rentscher KE, Root JC, Saykin AJ, Tometich DB, Van Dyk K, Zhai W, Breen EC, Carroll JE. Plasma levels of interleukin-6 mediate neurocognitive performance in older breast cancer survivors: The Thinking and Living With Cancer study. Cancer. 2023 Aug.129(15):2409-2421. Pubmedid: 37096888.
    • Rodriquenz MG, Negrete-Najar JP, Sam C, Sehovic M, Extermann M. Assessment of the external validity of the National Comprehensive Cancer Network (NCCN) guidelines for pancreatic ductal adenocarcinoma in a population of older patients aged 70 years and older. Geriatr Oncol. 2022 Sep.13(7):952-961. Pubmedid: 35597730.
    • Crowder SL, Hoogland AI, Small BJ, Carpenter KM, Fischer SM, Li D, Kinney AY, Welniak TL, Brownstein N, Reich RR, Hembree T, Extermann M, Kim R, Afiat TP, Berry DL, Turner K, Jim HSL. Associations among frailty and quality of life in older patients with cancer treated with chemotherapy. Geriatr Oncol. 2022 Nov.13(8):1149-1155. Pubmedid: 36008271. Pmcid: PMC9871794.
    • Root JC, Zhou X, Ahn J, Small BJ, Zhai W, Bethea T, Carroll JE, Cohen HJ, Dilawari A, Extermann M, Graham D, Isaacs C, Jacobsen PB, Jim H, McDonald BC, Nakamura ZM, Patel SK, Rentscher K, Saykin AJ, Van Dyk K, Mandelblatt JS, Ahles TA. Association of markers of tumor aggressivity and cognition in women with breast cancer before adjuvant treatment: The Thinking and Living with Cancer Study. Breast Cancer Res Treat. 2022 Jul.194(2):413-422. Pubmedid: 35587324. Pmcid: PMC9392482.
    • Small BJ, Lange M, Zhai W, Ahn J, Ahles TA, Carroll JE, Cohen HJ, Graham D, Extermann M, Heutte N, Jim HSL, McDonald BC, Patel SK, Root JC, Saykin AJ, Van Dyk K, Zhou X, Mandelblatt J, Joly F. Impact of taxane-based chemotherapy among older women with breast cancer on cognition and quality of life: a longitudinal pooled analysis. Breast Cancer Res Treat. 2022 Jan.191(2):459-469. Pubmedid: 34817750. Pmcid: PMC8766903.
    • Crowder SL, Hoogland AI, Welniak TL, LaFranchise EA, Carpenter KM, Li D, Rotroff DM, Mariam A, Pierce CM, Fischer SM, Kinney AY, Dong-Binh Tran T, Rastegari F, Berry DL, Extermann M, Kim RD, Tometich DB, Figueiredo JC, Muzaffar J, Bari S, Turner K, Weinstock GM, Jim HSL. Metagenomics and chemotherapy-induced nausea: A roadmap for future research. Cancer. 2022 Feb.128(3):461-470. Pubmedid: 34643945. Pmcid: PMC8776572.
    • Crowder SL, Welniak TL, Hoogland AI, Small BJ, Rodriguez Y, Carpenter KM, Fischer SM, Li D, Kinney AY, Rotroff D, Mariam A, Brownstein N, Reich RR, Hembree T, Playdon MC, Arthur AE, Vieytes CA, Li Z, Extermann M, Kim R, Berry DL, Jim HSL. Diet quality indices and changes in cognition during chemotherapy. Support Care Cancer. 2022 Dec.31(1):75. Pubmedid: 36544032. Pmcid: PMC10127432.
    • Le-Rademacher J, Mohile S, Unger J, Hudson MF, Foster J, Lichtman S, Perlmutter J, Dotan E, Extermann M, Dodd K, Tew W, Klepin H, Wildes TM, Sedrak MS, Jatoi A, Little RF. Trial Design Considerations to Increase Older Adult Accrual to National Cancer Institute Clinical Trials. J Natl Cancer Inst Monogr. 2022 Dec.2022(60):135-141. Pubmedid: 36519818.
    • Al-Jumayli M, Brown SL, Chetty IJ, Extermann M, Movsas B. The Biological Process of Aging and the Impact of Ionizing Radiation. Semin Radiat Oncol. 2022 Apr.32(2):172-178. Pubmedid: 35307120.
    • Extermann M, Chetty IJ, Brown SL, Al-Jumayli M, Movsas B. Predictors of Toxicity Among Older Adults with Cancer. Semin Radiat Oncol. 2022 Apr.32(2):179-185. Pubmedid: 35307121.
    • Extermann M, Hernández-Favela CG, Soto Perez de Celis E, Kanesvaran R. Global Aging and Cancer: Advancing Care Through Innovation. Am Soc Clin Oncol Educ Book. 2022 Apr.42:1-8. Pubmedid: 35452248.
    • Dotan E, Walter LC, Browner IS, Clifton K, Cohen HJ, Extermann M, Gross C, Gupta S, Hollis G, Hubbard J, Jagsi R, Keating NL, Kessler E, Koll T, Korc-Grodzicki B, McKoy JM, Misra S, Moon D, O'Connor T, Owusu C, Rosko A, Russell M, Sedrak M, Siddiqui F, Stella A, Stirewalt DL, Subbiah IM, Tew WP, Williams GR, Hollinger L, George GV, Sundar H. NCCN Guidelines® Insights: Older Adult Oncology, Version 1.2021. J Natl Compr Canc Ne. 2021 Sep.19(9):1006-1019. Pubmedid: 34551388.
    • Hembree T, Theou O, Thirlwell S, Reich RR, Cao B, Sehovic M, Syed M, Verma N, Nguyen TC, Keerty D, Wesolow J, Koverzhenko V, Extermann M, Huang J, Ramsakal A. A simple test-based frailty index to predict survival among cancer patients with an unplanned hospitalization: An observational cohort study. Cancer Med. 2021 Sep.10(17):5765-5774. Pubmedid: 34350715. Pmcid: PMC8419777.
    • McClennon J, Vonnes C, Dosal B, Reich RR, Mason TM, Extermann M. Integrating geriatric screening in the clinical setting: Recommendations for older adult oncology patients. Geriatr Oncol. 2021 Sep.12(7):1010-1014. Pubmedid: 33814340.
    • Mandelblatt JS, Zhou X, Small BJ, Ahn J, Zhai W, Ahles T, Extermann M, Graham D, Jacobsen PB, Jim H, McDonald BC, Patel SK, Root JC, Saykin AJ, Cohen HJ, Carroll JE. Response to Dekker, Stege, and Versteeg. J Natl Cancer Inst. 2021 Oct.113(10):1436-1437. Pubmedid: 33823011. Pmcid: PMC8486326.
    • Extermann M. Living longer and better with haematological malignancies: a promise for older adults too?. Lancet Haematol. 2021 Nov.8(11):e784-e786. Pubmedid: 34624240.
    • Mills M, Liveringhouse C, Lee F, Nanda RH, Ahmed KA, Washington IR, Thapa R, Fridley BL, Blumencranz P, Extermann M, Loftus L, Balducci L, Diaz R. The prevalence of luminal B subtype is higher in older postmenopausal women with ER+/HER2- breast cancer and is associated with inferior outcomes. Geriatr Oncol. 2021 Mar.12(2):219-226. Pubmedid: 32859560. Pmcid: PMC7907245.
    • Mallen A, Todd S, Robertson SE, Kim J, Sehovic M, Wenham RM, Extermann M, Chon HS. Impact of age, comorbidity, and treatment characteristics on survival in older women with advanced high grade epithelial ovarian cancer. Gynecol Oncol. 2021 Jun.161(3):693-699. Pubmedid: 33812698.
    • Fusco MJ, Saeed-Vafa D, Carballido EM, Boyle TA, Malafa M, Blue KL, Teer JK, Walko CM, McLeod HL, Hicks JK, Extermann M, Fleming JB, Knepper TC, Kim DW. Identification of Targetable Gene Fusions and Structural Rearrangements to Foster Precision Medicine in KRAS Wild-Type Pancreatic Cancer. JCO Precis Oncol. 2021 Jan.5. Pubmedid: 34250383. Pmcid: PMC8232071.
    • Extermann M, Brain E, Canin B, Cherian MN, Cheung KL, de Glas N, Devi B, Hamaker M, Kanesvaran R, Karnakis T, Kenis C, Musolino N, O'Donovan A, Soto-Perez-de-Celis E, Steer C, Wildiers H. Priorities for the global advancement of care for older adults with cancer: an update of the International Society of Geriatric Oncology Priorities Initiative. Lancet Oncol. 2021 Jan.22(1):e29-e36. Pubmedid: 33387502.
    • Mandelblatt JS, Zhou X, Small BJ, Ahn J, Zhai W, Ahles T, Extermann M, Graham D, Jacobsen PB, Jim H, McDonald BC, Patel S, Root JC, Saykin AJ, Cohen HJ, Carroll JE. Deficit Accumulation Frailty Trajectories of Older Breast Cancer Survivors and Non-Cancer Controls: The Thinking and Living With Cancer Study. J Natl Cancer Inst. 2021 Aug.113(8):1053-1064. Pubmedid: 33484565. Pmcid: PMC8328973.
    • Reljic T, Sehovic M, Lancet J, Kim J, Al Ali N, Djulbegovic B, Extermann M. Benchmarking treatment effects for patients over 70 with acute myeloid leukemia: A systematic review and meta-analysis. Geriatr Oncol. 2020 Nov.11(8):1293-1308. Pubmedid: 32665186. Pmcid: PMC7864384.
    • Tralongo AC, Extermann M. Older patients with cancer and febrile neutropenia in the COVID-19 era: A new concern. Geriatr Oncol. 2020 Nov.11(8):1329-1330. Pubmedid: 32571666. Pmcid: PMC7301139.
    • de Boer AZ, van de Water W, Bastiaannet E, de Glas NA, Kiderlen M, Portielje JEA, Extermann M. Early stage breast cancer treatment and outcome of older patients treated in an oncogeriatric care and a standard care setting: an international comparison. Breast Cancer Res Treat. 2020 Nov.184(2):519-526. Pubmedid: 32813120. Pmcid: PMC7599178.
    • Melody M, Kuykendall A, Sallman D, Al Ali N, Zhang L, Talati C, Padron E, Sweet K, Extermann M, List A, Lancet J, Komrokji R. Defining Acute Myeloid Leukemia Ontogeny in Older Patients. Clin Lymphoma Myeloma Leuk. 2020 May.20(5):312-315. Pubmedid: 32139296.
    • Mandelblatt JS, Zhai W, Ahn J, Small BJ, Ahles TA, Carroll JE, Denduluri N, Dilawari A, Extermann M, Graham D, Hurria A, Isaacs C, Jacobsen PB, Jim HSL, Luta G, McDonald BC, Patel SK, Root JC, Saykin AJ, Tometich DB, Zhou X, Cohen HJ. Symptom burden among older breast cancer survivors: The Thinking and Living With Cancer (TLC) study. Cancer. 2020 Mar.126(6):1183-1192. Pubmedid: 31860135. Pmcid: PMC7255412.
    • Song EY, Frakes JM, Extermann M, Klocksieben F, Mehta R, Saeed S, Hoffe SE, Pimiento JM. Clinical Factors and Outcomes of Octogenarians Receiving Curative Surgery for Esophageal Cancer. J Surg Res. 2020 Jul.251:100-106. Pubmedid: 32114211.
    • Talati C, Dhulipala VC, Extermann M, Al Ali N, Kim J, Komrokji R, Sweet K, Kuykendall A, Sehovic M, Reljic T, Djulbegovic B, Lancet JE. Comparisons of commonly used front-line regimens on survival outcomes in patients aged 70 years and older with acute myeloid leukemia. Haematologica. 2020 Jan.105(2):398-406. Pubmedid: 31073071. Pmcid: PMC7012500.
    • Mishra A, Bigam KD, Extermann M, Faramand R, Thomas K, Pidala JA, Baracos VE. Sarcopenia and low muscle radiodensity associate with impaired FEV1 in allogeneic haematopoietic stem cell transplant recipients. J Cachexia Sarcopenia Muscle. 2020 Dec.11(6):1570-1579. Pubmedid: 32729255. Pmcid: PMC7749567.
    • Kim KH, Lee JJ, Kim J, Zhou JM, Gomes F, Sehovic M, Extermann M. Association of multidimensional comorbidities with survival, toxicity, and unplanned hospitalizations in older adults with metastatic colorectal cancer treated with chemotherapy. Geriatr Oncol. 2019 Sep.10(5):733-741. Pubmedid: 30765268. Pmcid: PMC6689443.
    • Hembree TN, Thirlwell S, Reich RR, Pabbathi S, Extermann M, Ramsakal A. Predicting survival in cancer patients with and without 30-day readmission of an unplanned hospitalization using a deficit accumulation approach. Cancer Med. 2019 Nov.8(15):6503-6518. Pubmedid: 31493342. Pmcid: PMC6825978.
    • Tometich DB, Small BJ, Carroll JE, Zhai W, Luta G, Zhou X, Kobayashi LC, Ahles T, Saykin AJ, Clapp JD, Jim HSL, Jacobsen PB, Hurria A, Graham D, McDonald BC, Denduluri N, Extermann M, Isaacs C, Dilawari A, Root J, Rini C, Mandelblatt JS. Pretreatment Psychoneurological Symptoms and Their Association With Longitudinal Cognitive Function and Quality of Life in Older Breast Cancer Survivors. J Pain Symptom Manag. 2019 Mar.57(3):596-606. Pubmedid: 30472317. Pmcid: PMC6382533.
    • Chon HS, Sehovic M, Marchion D, Walko C, Xiong Y, Extermann M. Biologic Mechanisms Linked to Prognosis in Ovarian Cancer that May Be Affected by Aging. J Cancer. 2019 Jun.10(12):2604-2618. Pubmedid: 31258768. Pmcid: PMC6584919.
    • Shafique M, Ismail-Khan R, Extermann M, Sullivan D, Goodridge D, Boulware D, Hogue D, Soliman H, Khong H, Han HS. A Phase II Trial of Selinexor (KPT-330) for Metastatic Triple-Negative Breast Cancer. Oncologist. 2019 Jul.24(7):887-e416. Pubmedid: 30996012. Pmcid: PMC6656474.
    • de Leede N, Bastiaannet E, van der Geest L, Egan K, van de Velde C, Balducci L, Bonsing B, Extermann M. An international comparison of treatment and short-term overall survival for older patients with pancreatic cancer. Geriatr Oncol. 2019 Jul.10(4):584-590. Pubmedid: 30799177.
    • Carroll JE, Small BJ, Tometich DB, Zhai W, Zhou X, Luta G, Ahles TA, Saykin AJ, Nudelman KNH, Clapp JD, Jim HS, Jacobsen PB, Hurria A, Graham D, McDonald BC, Denduluri N, Extermann M, Isaacs C, Dilawari AA, Root J, Stern RA, Mandelblatt JS. Sleep disturbance and neurocognitive outcomes in older patients with breast cancer: Interaction with genotype. Cancer. 2019 Dec.125(24):4516-4524. Pubmedid: 31553501. Pmcid: PMC6891125.
    • Mandelblatt JS, Small BJ, Luta G, Hurria A, Jim H, McDonald BC, Graham D, Zhou X, Clapp J, Zhai W, Breen E, Carroll JE, Denduluri N, Dilawari A, Extermann M, Isaacs C, Jacobsen PB, Kobayashi LC, Holohan Nudelman K, Root J, Stern RA, Tometich D, Turner R, VanMeter JW, Saykin AJ, Ahles T. Cancer-Related Cognitive Outcomes Among Older Breast Cancer Survivors in the Thinking and Living With Cancer Study. J Clin Oncol. 2018 Oct.JCO1800140. Pubmedid: 30281396. Pmcid: PMC7237199.
    • Dougoud-Chauvin V, Lee JJ, Santos E, Williams VL, Battisti NML, Ghia K, Sehovic M, Croft C, Kim J, Balducci L, Kish JA, Extermann M. Using Big Data in oncology to prospectively impact clinical patient care: A proof of concept study. Geriatr Oncol. 2018 Nov.9(6):665-672. Pubmedid: 29678669. Pmcid: PMC6192862.
    • Extermann M. Celebrating a giant in geriatric oncology. Geriatr Oncol. 2018 May.9(3):181-182. Pubmedid: 29545084.
    • Lee JJ, Kim J, Sehovic M, Chen L, Extermann M. Using heat maps to assess the multidimensional association of comorbidities with survival in older cancer patients treated with chemotherapy. Geriatr Oncol. 2017 Sep.8(5):336-342. Pubmedid: 28739160. Pmcid: PMC5581700.
    • Battisti NML, Sehovic M, Extermann M. Assessment of the External Validity of the National Comprehensive Cancer Network and European Society for Medical Oncology Guidelines for Non-Small-Cell Lung Cancer in a Population of Patients Aged 80 Years and Older. Clin Lung Cancer. 2017 Sep.18(5):460-471. Pubmedid: 28416124.
    • Extermann M, Leeuwenburgh C, Samiian L, Sehovic M, Xu J, Cubitt C, Jacobsen PB, Pahor M, Grobmyer SR, Manini TM. Impact of chemotherapy on medium-term physical function and activity of older breast cancer survivors, and associated biomarkers. Geriatr Oncol. 2017 Jan.8(1):69-75. Pubmedid: 27743848. Pmcid: PMC5299045.
    • Extermann M. Cancer in the Elderly: Moving the Needle Toward Evidence-Based Personalized Oncology. Int J Radiat Oncol Biol Phys. 2017 07.98(4):718-720. Pubmedid: 28602406.
    • VanderWalde N, Jagsi R, Dotan E, Baumgartner J, Browner IS, Burhenn P, Cohen HJ, Edil BH, Edwards B, Extermann M, Ganti AK, Gross C, Hubbard J, Keating NL, Korc-Grodzicki B, McKoy JM, Medeiros BC, Mrozek E, O'Connor T, Rugo HS, Rupper RW, Shepard D, Silliman RA, Stirewalt DL, Tew WP, Walter LC, Wildes T, Bergman MA, Sundar H, Hurria A. NCCN Guidelines Insights: Older Adult Oncology, Version 2.2016. J Natl Compr Canc Ne. 2016 Nov.14(11):1357-1370. Pubmedid: 27799507.
    • Magnuson A, Allore H, Cohen HJ, Mohile SG, Williams GR, Chapman A, Extermann M, Olin RL, Targia V, Mackenzie A, Holmes HM, Hurria A. Geriatric assessment with management in cancer care: Current evidence and potential mechanisms for future research. Geriatr Oncol. 2016 Jul.7(4):242-248. Pubmedid: 27197915. Pmcid: PMC4969156.
    • Williams GR, Mackenzie A, Magnuson A, Olin R, Chapman A, Mohile S, Allore H, Somerfield MR, Targia V, Extermann M, Cohen HJ, Hurria A, Holmes H. Comorbidity in older adults with cancer. Geriatr Oncol. 2016 Jul.7(4):249-257. Pubmedid: 26725537. Pmcid: PMC4917479.
    • Mohile SG, Hurria A, Cohen HJ, Rowland JH, Leach CR, Arora NK, Canin B, Muss HB, Magnuson A, Flannery M, Lowenstein L, Allore HG, Mustian KM, Demark-Wahnefried W, Extermann M, Ferrell B, Inouye SK, Studenski SA, Dale W. Improving the quality of survivorship for older adults with cancer. Cancer. 2016 Aug.122(16):2459-2568. Pubmedid: 27172129. Pmcid: PMC4974133.
    • Extermann M, Reich RR, Sehovic M. Chemotoxicity recurrence in older patients: Risk factors and effectiveness of preventive strategies-a prospective study. Cancer. 2015 Sep.121(17):2984-2992. Pubmedid: 26033177. Pmcid: PMC4545718.
    • Decoster L, Van Puyvelde K, Mohile S, Wedding U, Basso U, Colloca G, Rostoft S, Overcash J, Wildiers H, Steer C, Kimmick G, Kanesvaran R, Luciani A, Terret C, Hurria A, Kenis C, Audisio R, Extermann M. Screening tools for multidimensional health problems warranting a geriatric assessment in older cancer patients: an update on SIOG recommendations†. Ann Oncol. 2015 Feb.26(2):288-300. Pubmedid: 24936581.
    • Dilling TJ, Extermann M, Kim J, Thompson LM, Yue B, Stevens CW, Antonia S, Gray J, Williams C, Haura E, Pinder-Schenck M, Tanvetyanon T, Kim S, Chiappori A. Phase 2 study of concurrent cetuximab plus definitive thoracic radiation therapy followed by consolidation docetaxel plus cetuximab in poor prognosis or elderly patients with locally advanced non-small cell lung cancer. Int J Radiat Oncol Biol Phys. 2014 Nov.90(4):828-833. Pubmedid: 25216856.
    • Kiderlen M, de Glas NA, Bastiaannet E, van de Water W, de Craen AJ, Guicherit OR, Merkus JW, Extermann M, van de Velde CJ, Liefers GJ. Impact of comorbidity on outcome of older breast cancer patients: a FOCUS cohort study. Breast Cancer Res Treat. 2014 May.145(1):185-192. Pubmedid: 24676624.
    • van de Water W, Bastiaannet E, Egan KM, de Craen AJ, Westendorp RG, Balducci L, van de Velde CJ, Liefers GJ, Extermann M. Management of primary metastatic breast cancer in elderly patients--an international comparison of oncogeriatric versus standard care. Geriatr Oncol. 2014 Jul.5(3):252-259. Pubmedid: 24661770. Pmcid: PMC4617765.
    • Popa MA, Wallace KJ, Brunello A, Extermann M, Balducci L. Potential drug interactions and chemotoxicity in older patients with cancer receiving chemotherapy. Geriatr Oncol. 2014 Jul.5(3):307-314. Pubmedid: 24821377. Pmcid: PMC4154059.
    • Hurria A, Wildes T, Blair SL, Browner IS, Cohen HJ, Deshazo M, Dotan E, Edil BH, Extermann M, Ganti AK, Holmes HM, Jagsi R, Karlekar MB, Keating NL, Korc-Grodzicki B, McKoy JM, Medeiros BC, Mrozek E, O'Connor T, Rugo HS, Rupper RW, Silliman RA, Stirewalt DL, Tew WP, Walter LC, Weir AB, Bergman MA, Sundar H. Senior adult oncology, version 2.2014: clinical practice guidelines in oncology . J Natl Compr Canc Ne. 2014 Jan.12(1):82-126. Pubmedid: 24453295.
    • Liu JJ, Druta M, Shibata D, Coppola D, Boler I, Elahi A, Reich RR, Siegel E, Extermann M. Metabolic syndrome and colorectal cancer: is hyperinsulinemia/insulin receptor-mediated angiogenesis a critical process?. Geriatr Oncol. 2014 Jan.5(1):40-48. Pubmedid: 24484717. Pmcid: PMC4527303.
    • Hurria A, Dale W, Mooney M, Rowland JH, Ballman KV, Cohen HJ, Muss HB, Schilsky RL, Ferrell B, Extermann M, Schmader KE, Mohile SG. Designing therapeutic clinical trials for older and frail adults with cancer: U13 conference recommendations. J Clin Oncol. 2014 Aug.32(24):2587-2594. Pubmedid: 25071116. Pmcid: PMC4129504.
    • Wildiers H, Heeren P, Puts M, Topinkova E, Janssen-Heijnen ML, Extermann M, Falandry C, Artz A, Brain E, Colloca G, Flamaing J, Karnakis T, Kenis C, Audisio RA, Mohile S, Repetto L, Van Leeuwen B, Milisen K, Hurria A. International Society of Geriatric Oncology consensus on geriatric assessment in older patients with cancer. J Clin Oncol. 2014 Aug.32(24):2595-2603. Pubmedid: 25071125. Pmcid: PMC4876338.
    • Ballman KV, Mauer M, Wedding U, Mohile SG, Muss H, Extermann M, Luciani A, Cohen HJ, Hurria A, Lichtman SM, Curigliano G, Wildiers H. Reply to L.K. Mell et al. J Clin Oncol. 2014 Apr.32(10):1090-1091. Pubmedid: 24550420.
    • Wildiers H, Mauer M, Pallis A, Hurria A, Mohile SG, Luciani A, Curigliano G, Extermann M, Lichtman SM, Ballman K, Cohen HJ, Muss H, Wedding U. End points and trial design in geriatric oncology research: a joint European organisation for research and treatment of cancer--Alliance for Clinical Trials in Oncology--International Society Of Geriatric Oncology position article. J Clin Oncol. 2013 Oct.31(29):3711-3718. Pubmedid: 24019549.
    • Muffly LS, Boulukos M, Swanson K, Kocherginsky M, Cerro PD, Schroeder L, Pape L, Extermann M, Van Besien K, Artz AS. Pilot study of comprehensive geriatric assessment (CGA) in allogeneic transplant: CGA captures a high prevalence of vulnerabilities in older transplant recipients. Biol Blood Marrow Tr. 2013 Mar.19(3):429-434. Pubmedid: 23160006.
    • Extermann M. Metabolic syndrome and cancer: from bedside to bench and back. Interdiscip Top Gerontol. 2013 Dec.38:49-60. Pubmedid: 23503515.
    • Extermann M. Metabolic syndrome, aging, and cancer. Crit Rev Oncog. 2013 Dec.18(6):515-529. Pubmedid: 24579732.
    • Robb C, Lee A, Jacobsen P, Dobbin KK, Extermann M. Health and personal resources in older patients with cancer undergoing chemotherapy. Geriatr Oncol. 2013 Apr.4(2):166-173. Pubmedid: 24071541. Pmcid: PMC4140217.
    • Movsas B, Extermann M. Introduction: Cancer, aging, and comorbidities. Semin Radiat Oncol. 2012 Oct.22(4):263-264. Pubmedid: 22985807.
    • Extermann M. Integrating a geriatric evaluation in the clinical setting. Semin Radiat Oncol. 2012 Oct.22(4):272-276. Pubmedid: 22985809.
    • Chen RC, Royce TJ, Extermann M, Reeve BB. Impact of age and comorbidity on treatment and outcomes in elderly cancer patients. Semin Radiat Oncol. 2012 Oct.22(4):265-271. Pubmedid: 22985808.
    • Extermann M, Boler I, Reich RR, Lyman GH, Brown RH, DeFelice J, Levine RM, Lubiner ET, Reyes P, Schreiber FJ, Balducci L. Predicting the risk of chemotherapy toxicity in older patients: the Chemotherapy Risk Assessment Scale for High-Age Patients (CRASH) score. Cancer. 2012 Jul.118(13):3377-3386. Pubmedid: 22072065.
    • Extermann M, Wedding U. Comorbidity and geriatric assessment for older patients with hematologic malignancies: a review of the evidence. J Geriatr Oncol. 2012 Jan.3:50-57.
    • Hurria A, Browner IS, Cohen HJ, Denlinger CS, deShazo M, Extermann M, Ganti AK, Holland JC, Holmes HM, Karlekar MB, Keating NL, McKoy J, Medeiros BC, Mrozek E, O'Connor T, Petersdorf SH, Rugo HS, Silliman RA, Tew WP, Walter LC, Weir AB, Wildes T. Senior adult oncology. J Natl Compr Canc Ne. 2012 Feb.10(2):162-209. Pubmedid: 22308515. Pmcid: PMC3656650.
    • Liu JJ, Extermann M. Comprehensive geriatric assessment and its clinical impact in oncology. Clin Geriatr Med. 2012 Feb.28(1):19-31. Pubmedid: 22326033.
    • Dale W, Mohile SG, Eldadah BA, Trimble EL, Schilsky RL, Cohen HJ, Muss HB, Schmader KE, Ferrell B, Extermann M, Nayfield SG, Hurria A. Biological, clinical, and psychosocial correlates at the interface of cancer and aging research. J Natl Cancer Inst. 2012 Apr.104(8):581-589. Pubmedid: 22457474. Pmcid: PMC3328422.
    • Extermann M. Basic assessment of the older cancer patient. CURR TREAT OPTION ON. 2011 Sep.12(3):276-285. Pubmedid: 21656152.
    • Gore E, Bae K, Langer C, Extermann M, Movsas B, Okunieff P, Videtic G, Choy H. Phase I/II trial of a COX-2 inhibitor with limited field radiation for intermediate prognosis patients who have locally advanced non-small-cell lung cancer: radiation therapy oncology group 0213. Clin Lung Cancer. 2011 Mar.12(2):125-130. Pubmedid: 21550559.
    • Brunello A, Kapoor R, Extermann M. Hyperglycemia during chemotherapy for hematologic and solid tumors is correlated with increased toxicity. Am J Clin Oncol. 2011 Jun.34(3):292-296. Pubmedid: 20622641.
    • Janssen-Heijnen ML, Extermann M, Boler IE. Can first cycle CBCs predict older patients at very low risk of neutropenia during further chemotherapy?. Crit Rev Oncol Hematol. 2011 Jul.79(1):43-50. Pubmedid: 20685130.
    • van Waalwijk MA, van de Schans SAM, Haak HR, Extermann M, Derckson MW, Janssen-Heijnen MLG. Diabetes alone should not be a motive for withholding adjuvant chemotherapy for stage III colon cancer. J Comorbid. 2011 Jan.1:19-27.
    • van Waalwijk MA, van de Schans SAM, Haak HR, Extermann M, Dercksen WMW, Janssen-Heijnen MLG. Diabetes alone should not be a reason for withholding adjuvant chemotherapy for stage III colon cancer. J Comorb. 2011.1:19-27. Pubmedid: 29090133. Pmcid: PMC5556418.
    • Robb C, Boulware D, Overcash J, Extermann M. Patterns of care and survival in cancer patients with cognitive impairment. Crit Rev Oncol Hematol. 2010 Jun.74(3):218-224. Pubmedid: 19709899.
    • Extermann M. Geriatric oncology: an overview of progresses and challenges. Cancer Res Treat. 2010 Jun.42(2):61-68. Pubmedid: 20622959. Pmcid: PMC2901078.
    • Hurria A, Cohen HJ, Extermann M. Geriatric Oncology Research in the Cooperative Groups: A Report of a SIOG Special Meeting. Geriatr Oncol. 2010 Jun.1(1):40-44. Pubmedid: 21218146. Pmcid: PMC3014580.
    • Extermann M. Larger questions about chemotherapy in older patients. Oncology (Williston Park). 2010 Jan.24(1):92-93. Pubmedid: 20187327.
    • Kumar NB, Kazi A, Smith T, Crocker T, Yu D, Reich RR, Reddy K, Hastings S, Exterman M, Balducci L, Dalton K, Bepler G. Cancer cachexia: traditional therapies and novel molecular mechanism-based approaches to treatment. CURR TREAT OPTION ON. 2010 Dec.11(3-4):107-117. Pubmedid: 21128029. Pmcid: PMC3016925.
    • Extermann M, Crane EJ, Boulware D. Cancer in nonagenarians: profile, treatments and outcomes. Crit Rev Oncol Hematol. 2010 Aug.75(2):160-164. Pubmedid: 20656211.
    • Luciani A, Jacobsen P, Extermann M, Foa P, Marussi D, Overcash J, BalducciL. Fatigue and functional dependence in older cancer patients. Am J Clin Oncol. 2008 Oct.31(5):424-430. Pubmedid: 18838877.
    • Simon GR, Extermann M, Chiappori A, Williams CC, Begum M, Kapoor R, Haura EB, Ismail-Khan R, Schell MJ, Antonia SJ, Bepler G. Phase 2 trial of docetaxel and gefitinib in the first-line treatment of patients with advanced nonsmall-cell lung cancer (NSCLC) who are 70 years of age or older. Cancer. 2008 May.112(9):2021-2029. Pubmedid: 18300255.
    • Extermann M, Hurria A. Comprehensive geriatric assessment for older patients with cancer. J Clin Oncol. 2007 May.25(14):1824-1831. Pubmedid: 17488980.
    • Extermann M. Interaction between comorbidity and cancer. Cancer Control. 2007 Jan.14(1):13-22. Pubmedid: 17242667.
    • Extermann M. Connecting trains. Cancer Control. 2007 Jan.14(1):4-5. Pubmedid: 17242665.
    • Wildiers H, Kunkler I, Biganzoli L, Fracheboud J, Vlastos G, Bernard-Marty C, Hurria A, Extermann M, Girre V, Brain E, Audisio R, Bartelink H, Barton M, Giordano S, Muss H, Aapro M. Management of breast cancer in elderly individuals: recommendations of the International Society of Geriatric Oncology. Lancet Oncol. 2007 Dec.8(12):1101-1115. Pubmedid: 18054880.
    • Robb C, Haley W, Balducci L, Extermann M, Perkins E, Small B, Mortimer J. Impact of breast cancer survivorship on quality of life in older women. Crit Rev Oncol Hematol. 2007 Apr.62(1):84-91. Pubmedid: 17188505.
    • Perkins EA, Small BJ, Balducci L, Extermann M, Robb C, Haley WE. Individual differences in well-being in older breast cancer survivors. Crit Rev Oncol Hematol. 2007 Apr.62(1):74-83. Pubmedid: 17240157. Pmcid: PMC1911161.
    • Extermann M. Treating advanced breast cancer in the older woman. Oncology (Williston Park). 2006 Oct.20(11):1355-1360. Pubmedid: 17111999.
    • Overcash J, Beckstead J, Moody L, Extermann M, Cobb S. The abbreviated comprehensive geriatric assessment (aCGA) for use in the older cancer patient as a prescreen: Scoring and interpretation. Crit Rev Oncol Hematol. 2006 Aug.59(3):205-210. Pubmedid: 16904902.
    • Artz A, Pollyea D, Kocherginsky M, Stock W, Rich E, Odenike O, ZimmermanT, Smith S, Godley L, Thirman M, Daugherty C, Extermann M, Larson R, van BesienK. Performance status and comorbidity predict transplant-related mortality after allogeneic hematopoietic cell transplantation. Biol Blood Marrow Tran. 2006 Aug.12(9):954-964. Pubmedid: 16920562.
    • Extermann M, Aapro M, Bernabei R, Cohen H, Droz J, Lichtman S, Mor V, Monfardini S, Repetto L, Sorbye L, Topinkova E. Use of comprehensive geriatric assessment in older cancer patients: recommendations from the task force on CGA of the International Society of Geriatric Oncology (SIOG). Crit Rev Oncol Hematol. 2005 Sep.55(3):241-252. Pubmedid: 16084735.
    • Naing A, Luong D, Extermann M. Methotrexate-induced status epilepticus. Am J Hematol. 2005 Sep.80(1):35-37. Pubmedid: 16138356.
    • Overcash J, Beckstead J, Extermann M, Cobb S. The abbreviated comprehensive geriatric assessment (aCGA): a retrospective analysis. Crit Rev Oncol Hematol. 2005 May.54(2):129-136. Pubmedid: 15843095.
    • Extermann M, Chen H, Booth-Jones M, Meyer J, Balducci L, Jacobsen P. Pilot testing of the computerized cognitive test Microcog in chemotherapy-treated older cancer patients. Crit Rev Oncol Hematol. 2005 May.54(2):137-143. Pubmedid: 15843096.
    • Aapro M, Kohne C, Cohen H, Extermann M. Never too old? Age should not be a barrier to enrollment in cancer clinical trials. Oncologist. 2005 Mar.10(3):198-204. Pubmedid: 15793223.
    • Mandelblatt JS, Schechter CB, Yabroff KR, Lawrence W, Dignam J, Extermann M, Fox S, Orosz G, Silliman R, Cullen J, Balducci L. Toward optimal screening strategies for older women. Costs, benefits, and harms of breast cancer screening by age, biology, and health status. J Gen Intern Med. 2005 Jun.20(6):487-496. Pubmedid: 15987322. Pmcid: PMC1490138.
    • Extermann M. Older patients, cognitive impairment, and cancer: an increasingly frequent triad. J Natl Compr Canc Ne. 2005 Jul.3(4):593-596. Pubmedid: 16038648.
    • Carreca I, Balducci L, Extermann M. Cancer in the older person. Cancer Treat Rev. 2005 Aug.31(5):380-402. Pubmedid: 15967582.
    • Extermann M. Biological basis of the association of cancer and aging comorbidity. Cancer Treat Res. 2005.124:173-186. Pubmedid: 15839196.
    • Extermann M. Decision analysis for cancer prevention and cancer treatment in the elderly. Cancer Treat Res. 2005.124:223-232. Pubmedid: 15839198.
    • Braud A, Extermann M. Biological screening and impact in elderly cancer patients. Cancer Treat Res. 2005.124:165-171. Pubmedid: 15839195.
    • Extermann M, Bonetti M, Sledge G, O'Dwyer P, Bonomi P, Benson AB 3rd. MAX2--a convenient index to estimate the average per patient risk for chemotherapy toxicity; validation in ECOG trials. Eur J Cancer. 2004 May.40(8):1193-1198. Pubmedid: 15110883.
    • Extermann M, Meyer J, McGinnis M, Crocker T, Corcoran M, Yoder J, Haley W, Chen H, Boulware D, Balducci L. A comprehensive geriatric intervention detects multiple problems in older breast cancer patients. Crit Rev Oncol Hematol. 2004 Jan.49(1):69-75. Pubmedid: 14734156.
    • Extermann M. Management issues for elderly patients with breast cancer. CURR TREAT OPTION ON. 2004 Apr.5(2):161-169. Pubmedid: 14990210.
    • Extermann M, Albrand G, Chen H, Zanetta S, Schonwetter R, Zulian G, Cantor A, Droz J. Are older French patients as willing as older American patients to undertake chemotherapy?. J Clin Oncol. 2003 Sep.21(17):3214-3219. Pubmedid: 12874269.
    • Extermann M, Balducci L. Optimizing cancer care in the elderly: progress in geriatric oncology. Cancer Control. 2003 Nov.10(6):440-441. Pubmedid: 14652519.
    • Extermann M. Studies of comprehensive geriatric assessment in patients with cancer. Cancer Control. 2003 Nov.10(6):463-468. Pubmedid: 14652522.
    • Extermann M. Paclitaxel pharmacokinetics, threshold models, and dosing strategies. J Clin Oncol. 2003 Jul.21(14):2804-2805. Pubmedid: 12860962.
    • Chen H, Cantor A, Meyer J, Corcoran M, Grendys E, Cavanaugh D, AntonekS, Camarata A, Haley W, Balducci L, Extermann M. Can older cancer patients tolerate chemotherapy? A prospective pilot study. Cancer. 2003 Feb.97(4):1107-1114. Pubmedid: 12569613.
    • Friberg M, Jennings R, Alsarraj M, Dessureault S, Cantor A, Extermann M, Mellor AL, Munn DH, Antonia SJ. Indoleamine 2,3-dioxygenase contributes to tumor cell evasion of T cell-mediated rejection. Int J Cancer. 2002 Sep.101(2):151-155. Pubmedid: 12209992.
    • Antonia S, Seigne J, Diaz J, Muro-Cacho C, Extermann M, Farmelo M, Friberg M, Alsarraj M, Mahany J, Pow-Sang J, Cantor A, Janssen W. Phase I trial of a B7-1 (CD80) gene modified autologous tumor cell vaccine in combination with systemic interleukin-2 in patients with metastatic renal cell carcinoma. J Urol. 2002 May.167(5):1995-2000. Pubmedid: 11956426.
    • Extermann M, Chen H, Cantor A, Corcoran M, Meyer J, Grendys E, CavanaughD, Antonek S, Camarata A, Haley W, Balducci L. Predictors of tolerance to chemotherapy in older cancer patients: a prospective pilot study. Eur J Cancer. 2002 Jul.38(11):1466-1473. Pubmedid: 12110492.
    • Balducci L, Extermann M, Carreca I. Management of breast cancer in the older woman. Cancer Control. 2001 Sep.8(5):431-441. Pubmedid: 11579340.
    • Balducci L, Extermann M. A practical approach to the older patient with cancer: a review. Curr Probl Cancer. 2001 Jan.25(1):6-76. Pubmedid: 11261937.
    • Overcash J, Extermann M, Parr J, Perry J, Balducci L. Validity and reliability of the FACT-G scale for use in the older person with cancer. Am J Clin Oncol. 2001 Dec.24(6):591-596. Pubmedid: 11801761.
    • Extermann M. Measurement and impact of comorbidity in older cancer patients. Crit Rev Oncol Hematol. 2000 Sep.35(3):181-200. Pubmedid: 10960800.
    • Extermann M. Challenges in geriatric oncology. Cancer Control. 2000 Nov.7(6):499-500. Pubmedid: 11088059.
    • Extermann M. Measuring comorbidity in older cancer patients. Eur J Cancer. 2000 Mar.36(4):453-471. Pubmedid: 10717521.
    • Mandelblatt J, Orosz G, Yabroff K, Extermann M, Lawrence W, Yi B, Satariano W, Bloom H, Fox S, Silliman R, Fahs M, Schecther C, Muenning P, Balducci L. Screening mammography in elderly women. Research on Breast Cancer in Older Women Consortium. Jama. 2000 Jun.283(24):3202-3203. Pubmedid: 10866863.
    • Extermann M, Aapro M. Assessment of the older cancer patient. Hematol Oncol Clin North Am. 2000 Feb.14(1):63-77, viii. Pubmedid: 10680072.
    • Balducci L, Extermann M. Cancer and aging. An evolving panorama. Hematol Oncol Clin North Am. 2000 Feb.14(1):1-16. Pubmedid: 10680068.
    • Balducci L, Extermann M. Management of the frail person with advanced cancer. Crit Rev Oncol Hematol. 2000 Feb.33(2):143-148. Pubmedid: 10737376.
    • Aapro M, Extermann M, Repetto L. Evaluation of the elderly with cancer. Ann Oncol. 2000 Dec.11(Suppl 3):223-229. Pubmedid: 11079145.
    • Extermann M, Balducci L, Lyman G. What threshold for adjuvant therapy in older breast cancer patients?. J Clin Oncol. 2000 Apr.18(8):1709-1717. Pubmedid: 10764431.
    • Balducci L, Extermann M. Management of cancer in the older person: a practical approach. Oncologist. 2000.5(3):224-237. Pubmedid: 10884501.
    • Balducci L, Extermann M. Cancer in the elderly. Clin Geriatr Med. 1999.6(13):51-58.
    • Extermann M, Bacchi M, Monai N, Fopp M, Fey M, Tichelli A, Schapira M, Spertini O. Relationship between cleaved L-selectin levels and the outcome of acute myeloid leukemia. Blood. 1998 Nov.92(9):3115-3122. Pubmedid: 9787146.
    • Extermann M, Overcash J, Lyman G, Parr J, Balducci L. Comorbidity and functional status are independent in older cancer patients. J Clin Oncol. 1998 Apr.16(4):1582-1587. Pubmedid: 9552069.
    • Balducci L, Extermann M. Difficulties in treating older patients with cancer. Oncology Pract. 1998.15-18. Pubmedid: noPMID.
    • Antonia S, Extermann M, Flavell R. Immunologic nonresponsiveness to tumors. Crit Rev Oncog. 1998.9(1):35-41. Pubmedid: 9754446.
    • Balducci L, Extermann M, Fentiman I, Monfardini S, Perrone F. Should adjuvant chemotherapy be used to treat breast cancer in elderly patients (> or = 70 years of age)?. Eur J Cancer. 1997 Oct.33(11):1720-1724. Pubmedid: 9470824.
    • Extermann M. Acute leukemia in the elderly. Clin Geriatr Med. 1997 May.13(2):227-244. Pubmedid: 9103206.
    • Balducci L, Extermann M. Cancer chemotherapy in the older person: what the medical oncologists needs to know. Cancer. 1997.80:1317-1322. Pubmedid: 9317185.
    • Balducci L, Extermann M. Advances in cancer therapy for the older patient. Intern Med. 1997.18:79-92. Pubmedid: noPIMID.
    • Extermann M, Balducci L, Lyman G. Optimal duration of adjuvant tamoxifen treatment in elderly breast cancer patients: influence of age, cormorbidites, and various effectiveness hypothesis on life-expectancy. Breast Dis. 1996.9:327-339.
    • Extermann M, Vogt N, Forni M, Dayer P. Radiation recall in a patient with breast cancer treated for tuberculosis. Eur J Clin Pharm. 1995.48:77-78. Pubmedid: 7621852.
    • Zulian G, Roux E, Tiercy J, Extermann M, Diebold-Berger S, Reymond J, Helg C, Zubler R, Betticher D, Alberto P, Jeannet M, Chapuis B. Transfusion associated graft versus host disease in a patient treated with cladribine (2-chlorodeoxyadenosine): demonstration of exogenous DNA in various tissue extracts. Brit J Hemat. 1995.89:83-89. Pubmedid: 7833282.
    • Extermann M, C Regamey, L Humair, Murisier F, Rhyner K, Vonwiller H. Initial treatment of sepsis in non-neutropenic patients: ceftazidime alone versus "best guess" combined antibiotic therapy. Chemotherapy. 1995.41:306-315. Pubmedid: 7555212.
    • Extermann M, Regamey C. Empirical antibiotic treatment of sepsis in non-neutropenic patients: single agent or combination therapy?. Infection. 1994.22:1-3.
    • Hayoz D, Extermann M, Odermatt B, Pugin P, Regamey C, Knecht H. Familial primary gastric lymphoma. Gut. 1993.34:136-140.
    • Extermann M. Comorbidity and geriatric assessment in the elderly patient over the age of 70. Tumori. 88(1 Suppl 1):S9. Pubmedid: 11989938.
    • Extermann M. Geriatric assessment with focus on instrument selectivity for outcomes. Cancer J. 11(6):474-480. Pubmedid: 16393481.
    • Extermann M. Comprehensive geriatric assessment basics for the cancer professional. J Oncol Manag. 12(2):13-17. Pubmedid: 12699111.
    • Balducci L, Extermann M. The cost of cancer prevention and treatment in the older person. In: The older cancer patient. New York, NY: Springer Publishing Company Inc; 2003;284-296.
    • Balducci L, Extermann M. Cancer and age. In: Haskell C, ed. Cancer treatment. Philadelphia, PA: W.B. Saunders; 2000;435-451.
    • Extermann M, Balducci L. Practical proposals for clinical protocols in elderly patients with cancer. In: Balducci L, Lyman G, Ershler W, et al, eds. Comprehensive Geriatric Oncology. Amsterdam. Harwood Academic Publishers; 1998;263-269.
    • International issues. In: Extermann M, Aapro M, eds. Cancer in the elderly. New York, NY: Marcel Dekker; 2000;459-476.
    • Balducci L, Extermann M. Issues in the care of the older cancer patient: delayed diagnosis, inadequate treatment, and information gaps. In: The older cancer patient. New York, NY: Springer Publishing Company Inc; 2003;24-44.
    • Balducci L, Extermann M. Cancer, carcinogenesis and aging. In: Rosenthal R, Zenilman M, Katlic M, et al, eds. Principles and practice of geriatric surgery. New York, NY: Springer Publishing Co Verlag; 2000;38-45.
  • Grants

    Title: Exploring the Use of a Web-Based Program for Older Adults Receiving Oral Anticancer Agents to Improve Communication and Self-Management
    Sponsor: Nat Institutes of Health
    PI: Extermann, M.
  • Patient Comments

    Overall Satisfaction


    222 patients rated this provider

    The Provider Rating is an average of all responses to specific care provider-related questions from our nationally-recognized Press Ganey Patient Satisfaction Survey. Responses are measured on a scale of 1 to 5 with 5 being the best score.

    Patients that are treated in outpatient or hospital environments may receive different surveys, and the volume of responses will vary by question.

    Learn more about our patient satisfaction survey



    Comments are gathered from specific care provider-related questions from our Patient Satisfaction Survey . The comments are submitted by patients and reflect their views and opinions. Patients are de-identified for confidentiality and patient privacy.

    We post both positive and negative comments from the surveys. We do not post comments that are libelous, slanderous, profane, irrelevant or otherwise inappropriate or may risk the privacy of our patients. A “[…]” in the comments below indicates de-identified patient information or comments that are unrelated to the patient’s experience with the visit to the provider, such as comments related to another provider, about the survey itself, or otherwise completely off-topic.

    Not all providers will have a star rating or comments. In order to ensure accuracy of our ratings, we only display ratings for providers who have a minimum of 30 completed from the previous 12 months.

    Learn more about our patient comments

    Provider Ratings and comments are gathered from our nationally-recognized Press Ganey Patient Satisfaction Survey. If a provider does not have ratings or comments listed it can be for several reasons, including:

    • The provider has not yet received the minimum number of patient satisfaction surveys to be eligible for display. We require a minimum of 30 surveys before we post results to ensure that the rating is statistically reliable and a true reflection of patient satisfaction.
    • He or she may be a researcher or other type of provider that does not see patients.
    • The provider practices in a specialty or office that does not use the specified surveys currently used for these ratings.

    Learn more about our patient satisfaction survey, ratings and comments

Find a Doctor